Prostate Cancer - Results from #680

ChatGPT can help guide and empower patients after prostate cancer diagnosis. June 28, 2024

Image-guided multiparametric magnetic resonance imaging-transrectal ultrasound fusion biopsy augmented with a sextant versus an extended template random biopsy: Comparison of cancer detection rates, complication and functional outcomes. June 28, 2024

Value of MRI - T2 Mapping to Differentiate Clinically Significant Prostate Cancer. June 28, 2024

Randomized trials of PSA screening. June 28, 2024

ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer. June 28, 2024

A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial. June 28, 2024

Prostate Cancer-Specific Lysine 53 Acetylation of Cytochrome c Drives Metabolic Reprogramming and Protects from Apoptosis in Intact Cells. June 28, 2024

Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers June 27, 2024

Prostate Cancer Among Black Men in Canada. June 27, 2024

MRI-guided Cryoablation of Prostate Cancer Lymph Node Metastasis. June 27, 2024

Retzius sparing robot-assisted radical prostatectomy: optimizing functional results. June 27, 2024

Therapy sequences and duration in mCRPC: a retrospective review of the Lübeck mCRPC cohort. June 27, 2024

Association of Baseline MRI PI-RADS Score With Prostate Cancer Active Surveillance Early Biopsy Reclassification: Data From the Michigan Urological Surgery Improvement Collaborative (MUSIC). June 27, 2024

High-volume surgeons decrease operating time in robot-assisted radical prostatectomy: results in 1229 patients. June 27, 2024

Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide. June 27, 2024

Enhanced Prostate-specific Membrane Antigen Targeting by Precision Control of DNA Scaffolded Nanoparticle Ligand Presentation. June 26, 2024

Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study. June 26, 2024

Docetaxel versus androgen receptor signaling inhibitor (ARSI) against chemo-naïve castration-resistant prostate cancer (CRPC): propensity score matched analysis in real world. June 26, 2024

Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate Cancer. June 26, 2024

Uptake of Same-Day Discharge for Patients Undergoing Robot-Assisted Radical Prostatectomy in the Michigan Urological Surgery Improvement Collaborative. June 26, 2024

Page 35 of 1436